Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pathogenesis and treatment of ANCA-associated systemic vasculitis.

× No keyword cloud information.

37 in total

Review 1. Treatment of antineutrophil cytoplasm autoantibody-associated systemic vasculitis: initiatives of the European Community Systemic Vasculitis Clinical Trials Study Group.

Authors: D R Jayne; N Rasmussen
Journal: Mayo Clin Proc Date: 1997-08 Impact factor: 7.616

2. Damage occurs early in systemic vasculitis and is an index of outcome.

Authors: A R Exley; D M Carruthers; R A Luqmani; G D Kitas; C Gordon; B A Janssen; C O Savage; P A Bacon
Journal: QJM Date: 1997-06

3. Peripheral blood T lymphocytes in systemic vasculitis: increased T cell receptor V beta 2 gene usage in microscopic polyarteritis.

Authors: I J Simpson; M A Skinner; A Geursen; J S Peake; W G Abbott; J D Fraser; C M Lockwood; P L Tan
Journal: Clin Exp Immunol Date: 1995-08 Impact factor: 4.330

4. Treatment of refractory Wegener's granulomatosis with humanized monoclonal antibodies.

Authors: C M Lockwood; S Thiru; S Stewart; G Hale; J Isaacs; P Wraight; J Elliott; H Waldmann
Journal: QJM Date: 1996-12

Review 5. Primary systemic vasculitis.

Authors: C O Savage; L Harper; D Adu
Journal: Lancet Date: 1997-02-22 Impact factor: 79.321

Review 6. Small-vessel vasculitis.

Authors: J C Jennette; R J Falk
Journal: N Engl J Med Date: 1997-11-20 Impact factor: 91.245

7. C-antineutrophil cytoplasmic antibody positivity in vasculitis patients is associated with the Z allele of alpha-1-antitrypsin, and P-antineutrophil cytoplasmic antibody positivity with the S allele.

Authors: M E Griffith; J U Lovegrove; G Gaskin; D B Whitehouse; C D Pusey
Journal: Nephrol Dial Transplant Date: 1996-03 Impact factor: 5.992

8. Effect of tumor necrosis factor-induced integrin activation on Fc gamma receptor II-mediated signal transduction: relevance for activation of neutrophils by anti-proteinase 3 or anti-myeloperoxidase antibodies.

Authors: D Reumaux; P J Vossebeld; D Roos; A J Verhoeven
Journal: Blood Date: 1995-10-15 Impact factor: 22.113

9. Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. Dutch Co-Trimoxazole Wegener Study Group.

Authors: C A Stegeman; J W Tervaert; P E de Jong; C G Kallenberg
Journal: N Engl J Med Date: 1996-07-04 Impact factor: 91.245

10. Antineutrophil cytoplasmic autoantibodies interact with primary granule constituents on the surface of apoptotic neutrophils in the absence of neutrophil priming.

Authors: H M Gilligan; B Bredy; H R Brady; M J Hébert; H S Slayter; Y Xu; J Rauch; M A Shia; J S Koh; J S Levine
Journal: J Exp Med Date: 1996-12-01 Impact factor: 14.307